BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37792522)

  • 1. Genetic risk assessment in breast and gynecologic malignancies- what's to know in 2024?
    Kamara D; Silver E; Niell-Swiller M
    Curr Opin Obstet Gynecol; 2024 Feb; 36(1):45-50. PubMed ID: 37792522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
    Kurian AW; Kingham KE; Ford JM
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):23-33. PubMed ID: 25502425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic screening for gynecological cancer: where are we heading?
    Manchanda R; Jacobs I
    Future Oncol; 2016 Jan; 12(2):207-20. PubMed ID: 26638726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
    Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
    Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of genetic testing for cancer susceptibility in gynecologic practice.
    Karlan BY; Berchuck A; Mutch D
    Obstet Gynecol; 2007 Jul; 110(1):155-67. PubMed ID: 17601911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counseling for hereditary breast and gynecologic cancer syndromes at a community hospital.
    Haber KM; Seagle BL; Drew B; Morrill-Cornelius S; Samuelson R; Hostmeyer S; Shahabi S
    Conn Med; 2014 Aug; 78(7):417-20. PubMed ID: 25195307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Chen LM; Richardson DL;
    Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic risk assessment for breast and gynecological malignancies.
    Profato JL; Arun BK
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):1-5. PubMed ID: 25502427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of genetic syndromes predisposing to gynecologic cancers.
    Miesfeldt S; Lamb A; Duarte C
    Curr Treat Options Oncol; 2013 Mar; 14(1):34-50. PubMed ID: 23315239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey.
    Kim M; Cheol Lim M; Ji Nam E; Huang D; Kim S; Jong Yoo H; Lee YY; Chang YJ;
    J Genet Couns; 2022 Apr; 31(2):546-553. PubMed ID: 34674340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
    Ballinger LL
    Obstet Gynecol Clin North Am; 2012 Jun; 39(2):165-81. PubMed ID: 22640709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in gynecologic cancer genetics evaluation.
    Hinchcliff EM; Bednar EM; Lu KH; Rauh-Hain JA
    Gynecol Oncol; 2019 Apr; 153(1):184-191. PubMed ID: 30711300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
    Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline and Somatic Tumor Testing in Gynecologic Cancer Care.
    Alldredge J; Randall L
    Obstet Gynecol Clin North Am; 2019 Mar; 46(1):37-53. PubMed ID: 30683265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary gynecologic cancers.
    Mutch D; Denny L; Quinn M;
    Int J Gynaecol Obstet; 2014 Mar; 124(3):189-92. PubMed ID: 24429354
    [No Abstract]   [Full Text] [Related]  

  • 18. Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.
    Tindale LC; Zhantuyakova A; Lam S; Woo M; Kwon JS; Hanley GE; Knoppers B; Schrader KA; Peacock SJ; Talhouk A; Dummer T; Metcalfe K; Pashayan N; Foulkes WD; Manchanda R; Huntsman D; Stuart G; Simard J; Dawson L
    Curr Oncol; 2022 Jun; 29(7):4632-4646. PubMed ID: 35877228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care.
    Senter L; O'Malley DM; Backes FJ; Copeland LJ; Fowler JM; Salani R; Cohn DE
    Gynecol Oncol; 2017 Oct; 147(1):110-114. PubMed ID: 28800943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
    Hall MJ; Obeid EI; Schwartz SC; Mantia-Smaldone G; Forman AD; Daly MB
    Gynecol Oncol; 2016 Mar; 140(3):565-74. PubMed ID: 26812021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.